BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 25745086)

  • 1. Comparative studies of three 68Ga-labeled [Des-Arg10]kallidin derivatives for imaging bradykinin B1 receptor expression with PET.
    Lin KS; Amouroux G; Pan J; Zhang Z; Jenni S; Lau J; Liu Z; Hundal-Jabal N; Colpo N; Bénard F
    J Nucl Med; 2015 Apr; 56(4):622-7. PubMed ID: 25745086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging Bradykinin B1 Receptor with 68Ga-Labeled [des-Arg10]Kallidin Derivatives: Effect of the Linker on Biodistribution and Tumor Uptake.
    Amouroux G; Pan J; Jenni S; Zhang C; Zhang Z; Hundal-Jabal N; Colpo N; Liu Z; Bénard F; Lin KS
    Mol Pharm; 2015 Aug; 12(8):2879-88. PubMed ID: 26101793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
    Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (18)F-trifluoroborate derivatives of [des-arg(10)]kallidin for imaging bradykinin b1 receptor expression with positron emission tomography.
    Liu Z; Amouroux G; Zhang Z; Pan J; Hundal-Jabal N; Colpo N; Lau J; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2015 Mar; 12(3):974-82. PubMed ID: 25629412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled R954 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography.
    Kuo HT; Pan J; Lau J; Zhang C; Zeisler J; Colpo N; Bénard F; Lin KS
    Mol Pharm; 2017 Mar; 14(3):821-829. PubMed ID: 28094956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a
    Amouroux G; Zhang Z; Pan J; Jenni S; Zhang C; Hundal-Jabal N; Colpo N; Zeisler J; Lin KS; Bénard F
    Bioorg Med Chem; 2017 Jan; 25(2):690-696. PubMed ID: 27908753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
    Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
    Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.
    Zhang C; Pan J; Lin KS; Dude I; Lau J; Zeisler J; Merkens H; Jenni S; Guérin B; Bénard F
    Mol Pharm; 2016 Nov; 13(11):3657-3664. PubMed ID: 27669056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo radioimaging of bradykinin receptor b1, a widely overexpressed molecule in human cancer.
    Lin KS; Pan J; Amouroux G; Turashvili G; Mesak F; Hundal-Jabal N; Pourghiasian M; Lau J; Jenni S; Aparicio S; Bénard F
    Cancer Res; 2015 Jan; 75(2):387-93. PubMed ID: 25488751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of (18)F-labeled bradykinin B1 receptor-targeting small molecules for PET imaging.
    Zhang Z; Kuo HT; Lau J; Jenni S; Zhang C; Zeisler J; Bénard F; Lin KS
    Bioorg Med Chem Lett; 2016 Aug; 26(16):4095-100. PubMed ID: 27390067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
    Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Essential role of TM V and VI for binding the C-terminal sequences of Des-Arg-kinins.
    Santos EL; de Picoli Souza K; Cibrián-Uhalte E; Oliveira SM; Bader M; Costa-Neto CM; Oliveira L; Pesquero JB
    Int Immunopharmacol; 2008 Feb; 8(2):282-8. PubMed ID: 18182241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modification of the highly potent peptide bradykinin B1 receptor antagonist B9958.
    Gera L; Stewart JM; Fortin JP; Morissette G; Marceau F
    Int Immunopharmacol; 2008 Feb; 8(2):289-92. PubMed ID: 18182242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation of a promising angiogenesis PET imaging agent: 68Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice.
    Jeong JM; Hong MK; Chang YS; Lee YS; Kim YJ; Cheon GJ; Lee DS; Chung JK; Lee MC
    J Nucl Med; 2008 May; 49(5):830-6. PubMed ID: 18413379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
    Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
    J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.